Epidemiology of Acute Mesenteric Ischemia

• Sponsor: Tartu University Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT04867499
• Collaborator: (none)
• Enrollment: 577
• Location: 1
• Actual Duration (Months): 3.9
• Patients Per Site Per Month: 147.6

Study Details

Study Description

Brief Summary

Retrospective population-based study on epidemiology of acute mesenteric ischemia in Estonia Study objective is to describe epidemiologic features in adult patients with acute mesenteric ischemia during years 2016-2020. Patients from all hospitals in Estonia are included.

Condition or Disease	Intervention/Treatment	Phase
Acute Mesenteric Ischemia	Other: No intervention

Study Design

• Study Type: Observational
• Actual Enrollment: 577 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Retrospective Population-based Study on Epidemiology of Acute Mesenteric Ischemia in Estonia
• Actual Study Start Date: Oct 5, 2021
• Actual Primary Completion Date: Feb 1, 2022
• Actual Study Completion Date: Feb 1, 2022

Outcome Measures

Primary Outcome Measures

1. Incidence [2016-2020]

   To identify the incidence of AMI in adult hospitalized patients in Estonia during 2016-2020

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

All at least 18-year-old patients with acute mesenteric ischemia during years 2016-2020.

Exclusion Criteria:

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Tartu University Hospital	Tartu		Estonia

Sponsors and Collaborators

• Tartu University Hospital

Investigators

None specified.

Study Documents (Full-Text)

• Study Protocol and Statistical Analysis Plan - Apr 1, 2021

More Information

Publications

None provided.

• Responsible Party: Karri Kase, Medical Doctor, Tartu University Hospital
• ClinicalTrials.gov Identifier: NCT04867499
• Other Study ID Numbers: 21021
• First Posted: Apr 30, 2021
• Last Update Posted: Mar 15, 2022
• Last Verified: Mar 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Mesenteric Ischemia; Ischemia

Study Results

No Results Posted as of Mar 15, 2022